Coronavirus Mortality Rate Upped to 3.4%; Increasing Need for Testing

With the world’s major health organization upping the mortality rate to 3.4%, there is increased need for a working rapid test for COVID-19 to be able to properly isolate patients and protect providers. The World Health Organization (WHO) has raised its estimate of the mortality rate of patients infected with the novel coronavirus to 3.4% […]

Thermo Fisher set to acquire Qiagen after all in $11.5B deal

Courtesy of March 3, 2020 — After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will give Thermo Fisher access to Qiagen’s molecular diagnostics expertise and potentially lead to faster development of diagnostic tests. The deal values Qiagen at 39 euros ($44) per […]

Expect to Hear a Lot of Talk about Coronavirus and Molecular Point of Care

A Harvard Business Review  article calls for molecular point of care to step in to detect #coronavirus. You’ll hear a lot of this in coming weeks, we think.  Molecular point of care is less than 10 years old but has shown promise in flu/strep, other respiratory pathogens. They are in the right place at the right […]

Molecular Diagnostics for Cancer Grows, Fueled by NGS-based Testing

Cancer diagnostics is a highly dynamic field that consists of various types of platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as well as prognosis evaluation, which are important for treatment decisions. In 2019, the market for molecular cancer diagnostics, including histology and assays, reached $1,600 million, increasing 11.5% over […]

Clinical Labs are a 120+ Billion-Dollar Industry Globally

The global market for clinical laboratory services is estimated at $121.5 billion for 2019.  This is up 2.9% from the estimated value in 2010 of $93.9 billion, according to a new Kalorama Information report.  ( ) Growth is driven by  an aging population, a growing incidence of chronic diseases, but it is more than that.  The […]

State of Mass Spectrometry in Clinical Labs

February 3, 2020 — For years, mass spectrometry found extensive use as a valuable analytical tool in industries ranging from chemical processing to drug discovery and development. Now the technology has transitioned into the clinical lab, with the commercialization of mass spectrometry platforms for microbial identification. In the clinical setting, mass spectrometry has gained attention as […]

Roche and Meridian Among Vendors with 2019-nCoV-related IVD products; FDA Steps in.

Major IVD vendors, especially those common in reverse transcription PCR (RT-PCR), went right to work in the recent coronavirus outbreak.  This as the FDA announced plans to make emergency test deployment easier.  The recent novel coronavirus, responsible for thousands of infections and over 170 deaths in the Hubei province in China at the time of […]

Barbershop Point of Care Testing? Study Shows it Might Be Effective

Point-of-care has potential to reach patients who may not even be aware they are patients, as evidenced by a recent study in a major journal that documented an unusual point-of-care venue: barbershops were found to be effective locations for on-the-spot testing of black men for hemoglobin A1c (HbA1c), according to a study published January 27 […]

AI in Healthcare, Nearly 2 Billion and Growing

Kalorama Information’s report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in diagnostics and other areas. The Market for Artificial Intelligence (AI) in Healthcare In the United […]

New Report Focuses on NASH Market Opportunity

It’s no surprise that many pharmaceutical companies are developing treatments for a disease affecting millions with no current therapy.  That disease is Non-alcoholic fatty liver disease (NAFLD).  NASH is a  lifestyle disease (obesity and lack of exercise) and is distinct from other fatty liver diseases caused by alcohol abuse or medication side effects.  The symptoms […]